108 related articles for article (PubMed ID: 10581371)
41. Angiographically occult brainstem vascular malformation: a longitudinal comparison of magnetic resonance imaging (MRI) and multimodal evoked potential (EP) recordings.
Pozzessere G; Valle E; Poggio P; Petrucci B; Petrucci A; Bianco F; Rizzo PA
Acta Neurol Belg; 1992; 92(2):65-76. PubMed ID: 1604962
[TBL] [Abstract][Full Text] [Related]
42. [Visual, early auditory and somatosensory evoked potentials in multiple sclerosis (917 cases)].
Fischer C; Mauguière F; Ibañez V; Courjon J
Rev Neurol (Paris); 1986; 142(5):517-23. PubMed ID: 3787054
[TBL] [Abstract][Full Text] [Related]
43. Visual and motor evoked potentials in the course of multiple sclerosis.
Fuhr P; Borggrefe-Chappuis A; Schindler C; Kappos L
Brain; 2001 Nov; 124(Pt 11):2162-8. PubMed ID: 11673318
[TBL] [Abstract][Full Text] [Related]
44. Correlation of MRI lesions with visual psychophysical deficit in secondary progressive multiple sclerosis.
Caruana PA; Davies MB; Weatherby SJ; Williams R; Haq N; Foster DH; Hawkins CP
Brain; 2000 Jul; 123 ( Pt 7)():1471-80. PubMed ID: 10869058
[TBL] [Abstract][Full Text] [Related]
45. Visual, long-latency auditory and brainstem auditory evoked potentials in migraine: relation to pattern size, stimulus intensity, sound and light discomfort thresholds and pre-attack state.
Sand T; Vingen JV
Cephalalgia; 2000 Nov; 20(9):804-20. PubMed ID: 11167910
[TBL] [Abstract][Full Text] [Related]
46. Sympathetic skin response (SSR) in multiple sclerosis and clinically isolated syndrome: a case-control study.
Aghamollaii V; Harirchian MH; Modabbernia A; Ghaffarpour M; Mousavi M; Tafakhori A
Neurophysiol Clin; 2011 Oct; 41(4):161-71. PubMed ID: 22078728
[TBL] [Abstract][Full Text] [Related]
47. Brainstem lesions may be important in the development of epilepsy in multiple sclerosis patients: an evoked potential study.
Papathanasiou ES; Pantzaris M; Myrianthopoulou P; Kkolou E; Papacostas SS
Clin Neurophysiol; 2010 Dec; 121(12):2104-10. PubMed ID: 20542465
[TBL] [Abstract][Full Text] [Related]
48. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
49. Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
Klistorner A; Garrick R; Barnett MH; Graham SL; Arvind H; Sriram P; Yiannikas C
Neurology; 2013 Jan; 80(3):242-5. PubMed ID: 23269599
[TBL] [Abstract][Full Text] [Related]
50. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
Abo-Krysha N; Rashed L
Mult Scler; 2008 Jun; 14(5):602-8. PubMed ID: 18408021
[TBL] [Abstract][Full Text] [Related]
51. Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
Schlaeger R; D'Souza M; Schindler C; Grize L; Kappos L; Fuhr P
Mult Scler; 2014 Jan; 20(1):51-6. PubMed ID: 23756680
[TBL] [Abstract][Full Text] [Related]
52. Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis.
Paran D; Chapman J; Korczyn AD; Elkayam O; Hilkevich O; Groozman GB; Levartovsky D; Litinsky I; Caspi D; Segev Y; Drory VE
Ann Rheum Dis; 2006 Apr; 65(4):525-8. PubMed ID: 16107510
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of patients with multiple sclerosis by evoked potentials and magnetic resonance imaging: a comparative study.
Cutler JR; Aminoff MJ; Brant-Zawadzki M
Ann Neurol; 1986 Nov; 20(5):645-8. PubMed ID: 3789682
[TBL] [Abstract][Full Text] [Related]
54. Some aspects of balance disorder in patients with multiple sclerosis.
Burina A; Sinanović O; Smajlović D; Vidović M; Brkić F
Bosn J Basic Med Sci; 2008 Feb; 8(1):80-5. PubMed ID: 18318678
[TBL] [Abstract][Full Text] [Related]
55. Brainstem auditory evoked potential in Japanese encephalitis.
Kalita J; Misra UK
J Neurol Sci; 1999 May; 165(1):24-7. PubMed ID: 10426142
[TBL] [Abstract][Full Text] [Related]
56. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis.
Rostami AM; Sater RA; Bird SJ; Galetta S; Farber RE; Kamoun M; Silberberg DH; Grossman RI; Pfohl D
Mult Scler; 1999 Jun; 5(3):198-203. PubMed ID: 10408721
[TBL] [Abstract][Full Text] [Related]
57. [Multimodal evoked potentials in the early period after cranio-cerebral trauma].
Liska A; Kazibutowska Z; Rogoz B; Pierzchała K; Rusiecki Z; Totuszyński M
Neurol Neurochir Pol; 1991; 25(5):647-55. PubMed ID: 1808527
[TBL] [Abstract][Full Text] [Related]
58. Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis.
Jung P; Beyerle A; Ziemann U
Mult Scler; 2008 May; 14(4):553-6. PubMed ID: 18562509
[TBL] [Abstract][Full Text] [Related]
59. CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study.
Uncini A; Gallucci M; Lugaresi A; Porrini AM; Onofrj M; Gambi D
Electromyogr Clin Neurophysiol; 1991 Sep; 31(6):365-71. PubMed ID: 1935761
[TBL] [Abstract][Full Text] [Related]
60. Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.
Weinstock-Guttman B; Baier M; Stockton R; Weinstock A; Justinger T; Munschauer F; Brownscheidle C; Williams J; Fisher E; Miller D; Rudick R
Mult Scler; 2003 Oct; 9(5):529-34. PubMed ID: 14582782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
